Loading...

CANCER MARKER PROFILE NEUROENDOCRINE TUMORS

image not found

NABL Cap Accredited 
The Neuroendocrine Tumor Cancer Marker Profile at Metropolis Healthcare evaluates blood markers associated with neuroendocrine tumors. This panel helps in early detection, monitoring disease progression, and assessing treatment response. Metropolis ensures precise results using advanced immunoassay technology and expert oncological interpretation.

  • 17 Crores+ Samples Processed
  • World Class Technology Labs
  • 25+ Years of Trust & Experience
  • Free Home Collection

Price: Rs. 6,570.00

Sample Type: Serum

Fasting Not Requierd


Booking Procedure:
  1. Technician from Metropolis will be assigned for a home sample collection after booking confirmation.
  2. Sample will be collected by our technician at your address at given slot.
  3. You can make the payment to the technician at the time of collection
  4. Your sample will then be transported to the nearest collection center and will be centrifuged before sending to the lab for processing.
  5. Soft copy reports will be sent to your email address within 24 to 48 hours or as per defined TAT for Tests.

Frequently Asked Questions (FAQ's):

What is included in the Neuroendocrine Tumor Cancer Marker Profile?
It typically includes markers such as Chromogranin A, NSE (Neuron-Specific Enolase), and other relevant tumor markers for neuroendocrine tumors.

Who should consider this test?
Patients with symptoms like flushing, diarrhea, unexplained weight loss, or suspected neuroendocrine tumors may benefit from this test.

How is the sample collected?
A blood sample is collected at Metropolis Healthcare for tumor marker analysis.

Is fasting required for this test?
Yes, fasting may be recommended for accurate measurement of some markers. Metropolis Healthcare provides guidance on preparation.

How accurate are the results from Metropolis Healthcare?
Metropolis ensures high accuracy using advanced immunoassay platforms, expert technicians, and strict quality control.

Can this test diagnose neuroendocrine tumors on its own?
No, it is a supportive diagnostic tool. Imaging and clinical evaluation are required for definitive diagnosis.

How often should this test be done?
Frequency depends on monitoring needs, treatment response, and doctor’s recommendations.

How does this test help in treatment planning?
It helps track therapy effectiveness, detect recurrence early, and guide clinical decision-making for neuroendocrine tumor management.

OUR corporates PARTNER

Feedback

Patient's Testimonials

Trusted by Thousands

OUR Accreditations

OUR Lab